Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 26 Aug 2024

Predicting radiotherapy efficacy and prognosis in tongue squamous cell carcinoma through an in-depth analysis of a radiosensitivity gene signature

in Cancer Immunity and Immunotherapy

Jinzhi Lai
Hainan Yang
Junjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1334747

1,089 views

Study Protocol

Published on 26 Aug 2024

iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens

in Cancer Immunity and Immunotherapy

Alexander Englisch
Clara Hayn
Susanne Jung
Jonas S. Heitmann
Christopher Hackenbruch
Yacine Maringer
Annika Nelde
Marcel Wacker
Monika Denk
Lisa Zieschang

Frontiers in Oncology

doi 10.3389/fonc.2024.1441625

1,643 views
1 citation

Original Research

Published on 26 Aug 2024

The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy

in Cancer Immunity and Immunotherapy

Yanyan Zhang
Jingxin Zhang
Shijie Shang
Jiachun Ma
Fei Wang
Meng Wu
Jinming Yu
Dawei Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1389804

1,257 views

Original Research

Published on 23 Aug 2024

A prognostic nomogram for patients with HR+ mucinous breast carcinoma based on the SEER database and a Chinese cohort study

in Cancer Immunity and Immunotherapy

Huiying Fang
Jian Yue
Hongzhong Li
Tiankuo Luan
Pin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1444531

1,293 views

Original Research

Published on 20 Aug 2024

Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis

in Cancer Immunity and Immunotherapy

Jie Yang
Haizan Yu
Yilei Zhang
Mingli Zhu
Mengyu Zhang
Qiming Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1454372

906 views
1 citation

Original Research

Published on 19 Aug 2024

Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer

in Cancer Immunity and Immunotherapy

Hongyuan Jia
Long Liang
Xue Chen
Wenzhong Zha
Wei Diao
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1380195

833 views

Case Report

Published on 16 Aug 2024

Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report

in Cancer Immunity and Immunotherapy

Wenjing Niu
Haimei Zhang
Xuezhen Ma
Hua Liang
Zhongshi Qiao
Zheng Wang
Lifeng Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1403762

1,084 views
1 citation

Case Report

Published on 14 Aug 2024

Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report

in Cancer Immunity and Immunotherapy

Yimeng Qian
Zheng Zhi
Jing Ai
Lin Kang
Gang Qiu
Xin Huang
Jing Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1415117

1,357 views
4 citations

Systematic Review

Published on 07 Aug 2024

Research hotspots and trend of glioblastoma immunotherapy: a bibliometric and visual analysis

in Cancer Immunity and Immunotherapy

Keren Lv
Xue Du
Chunbao Chen
Yina Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1361530

2,580 views
1 citation

Case Report

Published on 29 Jul 2024

Sequential severe immune-related adverse events induced by PD-1 inhibitor: a case report and literature review

in Cancer Immunity and Immunotherapy

Jinxiong Xia
Yingmei Wen
Mengxia Xiao
Dafu Ye
Yanjun Gao
Dongling Tang
Xiuyun Zhang
Jinling Chen
Qingqing Li
Yi Yao

Frontiers in Oncology

doi 10.3389/fonc.2024.1391698

1,315 views
2 citations

Original Research

Published on 24 Jul 2024

Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer

in Cancer Immunity and Immunotherapy

George Alzeeb
Corinne Tortorelli
Jaqueline Taleb
Fanny De Luca
Benoit Berge
Chloé Bardet
Emeric Limagne
Marion Brun
Lionel Chalus
Benoit Pinteur

Frontiers in Oncology

doi 10.3389/fonc.2024.1427428

5,468 views

Case Report

Published on 23 Jul 2024

Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma

in Cancer Immunity and Immunotherapy

Mi Meng
Bo Yu
Jie Luo
Yuju Bai
Lin Li
Shicheng Chen
Sisi He
Hu Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1326006

1,046 views

Case Report

Published on 18 Jul 2024

Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature

in Cancer Immunity and Immunotherapy

Marie-Florence Reveneau
Julien Masliah-Planchon
Manuel Fernandez
Abdenour Ouikene
Bernard Dron
Innocenti Dadamessi
Charles Dayen
Lisa Golmard
Bruno Chauffert

Frontiers in Oncology

doi 10.3389/fonc.2024.1410322

2,660 views
1 citation

Review

Published on 16 Jul 2024

Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review

in Cancer Immunity and Immunotherapy

Jiamin Xu
Shukun Mu
Yun Wang
Suchun Yu
Zhongming Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1400193

3,106 views
3 citations

Review

Published on 10 Jul 2024

The investigation of oncolytic viruses in the field of cancer therapy

in Cancer Immunity and Immunotherapy

Zijun Yuan
Yinping Zhang
Xiang Wang
Xingyue Wang
Siqi Ren
Xinyu He
Jiahong Su
Anfu Zheng
Sipeng Guo
Yu Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1423143

2,915 views
2 citations

Systematic Review

Published on 08 Jul 2024

Unveiling the landscape of pathomics in personalized immunotherapy for lung cancer: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Lei Yuan
Zhiming Shen
Yibo Shan
Jianwei Zhu
Qi Wang
Yi Lu
Hongcan Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1432212

2,420 views
1 citation